메뉴 건너뛰기




Volumn 116, Issue 4, 2016, Pages 321-328.e1

Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; FRACTION OF EXHALED NITRIC OXIDE; ICOSANOID; LEUKOTRIENE E4; NITRIC OXIDE; UNCLASSIFIED DRUG; ALLERGEN;

EID: 84955617566     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2015.12.026     Document Type: Article
Times cited : (13)

References (45)
  • 1
    • 27644447206 scopus 로고    scopus 로고
    • Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma
    • K. Mascia, T. Haselkorn, Y.M. Deniz, and et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma J Allergy Clin Immunol 116 2005 970 975
    • (2005) J Allergy Clin Immunol , vol.116 , pp. 970-975
    • Mascia, K.1    Haselkorn, T.2    Deniz, Y.M.3
  • 2
    • 0037391750 scopus 로고    scopus 로고
    • 2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge
    • 2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge J Allergy Clin Immunol 111 2003 743 749
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 743-749
    • Bochenek, G.1    Nagraba, K.2    Nizankowska, E.3    Szczeklik, A.4
  • 5
    • 77951768969 scopus 로고    scopus 로고
    • Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers
    • N. Higashi, H. Mita, E. Ono, and et al. Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers J Allergy Clin Immunol 125 2010 1084 1091
    • (2010) J Allergy Clin Immunol , vol.125 , pp. 1084-1091
    • Higashi, N.1    Mita, H.2    Ono, E.3
  • 8
    • 0027462391 scopus 로고
    • Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma
    • K. Sladek, and A. Szczeklik Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma Eur Respir J 6 1993 391 399
    • (1993) Eur Respir J , vol.6 , pp. 391-399
    • Sladek, K.1    Szczeklik, A.2
  • 9
    • 84908133226 scopus 로고    scopus 로고
    • Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study
    • M. Swierczynska-Krepa, M. Sanak, G. Bochenek, and et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study J Allergy Clin Immunol 134 2014 883 890
    • (2014) J Allergy Clin Immunol , vol.134 , pp. 883-890
    • Swierczynska-Krepa, M.1    Sanak, M.2    Bochenek, G.3
  • 11
    • 0026760459 scopus 로고
    • Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge
    • U.R. Juergens, S.C. Christiansen, D.D. Stevenson, and B.L. Zuraw Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge J Allergy Clin Immunol 90 1992 636 645
    • (1992) J Allergy Clin Immunol , vol.90 , pp. 636-645
    • Juergens, U.R.1    Christiansen, S.C.2    Stevenson, D.D.3    Zuraw, B.L.4
  • 14
  • 15
    • 59449099804 scopus 로고    scopus 로고
    • Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease
    • A.P. Hope, K.A. Woessner, R.A. Simon, and D.D. Stevenson Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 123 2009 406 410
    • (2009) J Allergy Clin Immunol , vol.123 , pp. 406-410
    • Hope, A.P.1    Woessner, K.A.2    Simon, R.A.3    Stevenson, D.D.4
  • 16
    • 33846820329 scopus 로고    scopus 로고
    • Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: A practice paper
    • E. Macy, J.A. Bernstein, M.C. Castells, and et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper Ann Allergy Asthma Immunol 98 2007 172 174
    • (2007) Ann Allergy Asthma Immunol , vol.98 , pp. 172-174
    • Macy, E.1    Bernstein, J.A.2    Castells, M.C.3
  • 17
    • 0021163545 scopus 로고
    • Dose-related kinetics of aspirin: Presystemic acetylation of platelet cyclooxygenase
    • A. Pedersen, and G.A. Fitzgerald Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase N Engl J Med 311 1984 1206 1211
    • (1984) N Engl J Med , vol.311 , pp. 1206-1211
    • Pedersen, A.1    Fitzgerald, G.A.2
  • 18
    • 84946410922 scopus 로고    scopus 로고
    • An hourly dose-escalation desensitization protocol for aspirin exacerbated respiratory disease
    • J.R. Chen, B.L. Buchmiller, and D.A. Khan An hourly dose-escalation desensitization protocol for aspirin exacerbated respiratory disease J Allergy Clin Immunol Pract 3 2015 926 931.e1
    • (2015) J Allergy Clin Immunol Pract , vol.3 , pp. 926-931e1
    • Chen, J.R.1    Buchmiller, B.L.2    Khan, D.A.3
  • 19
    • 77957795704 scopus 로고    scopus 로고
    • The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases
    • R.K. Katial, M. Strand, T. Prasertsuntarasai, R. Leung, W. Zheng, and R. Alam The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases J Allergy Clin Immunol 126 2010 738 744
    • (2010) J Allergy Clin Immunol , vol.126 , pp. 738-744
    • Katial, R.K.1    Strand, M.2    Prasertsuntarasai, T.3    Leung, R.4    Zheng, W.5    Alam, R.6
  • 20
    • 3442901155 scopus 로고    scopus 로고
    • Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma
    • G. Rolla, A. Di Emanuele, L. Dutto, and et al. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma Allergy 59 2004 827 832
    • (2004) Allergy , vol.59 , pp. 827-832
    • Rolla, G.1    Di Emanuele, A.2    Dutto, L.3
  • 21
    • 84871047455 scopus 로고    scopus 로고
    • Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease
    • D. Tworek, I. Kuprys-Lipinska, W. Pietruszewska, and P. Kuna Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease Am J Rhinol Allergy 26 2012 428 432
    • (2012) Am J Rhinol Allergy , vol.26 , pp. 428-432
    • Tworek, D.1    Kuprys-Lipinska, I.2    Pietruszewska, W.3    Kuna, P.4
  • 23
    • 26944473225 scopus 로고    scopus 로고
    • The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease
    • A.A. White, D.D. Stevenson, and R.A. Simon The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 95 2005 330 335
    • (2005) Ann Allergy Asthma Immunol , vol.95 , pp. 330-335
    • White, A.A.1    Stevenson, D.D.2    Simon, R.A.3
  • 24
    • 0027564322 scopus 로고
    • Lung volumes and forced ventilatory flows: Report of the Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society
    • P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows: report of the Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: Official Statement of the European Respiratory Society Eur Respir J 16 suppl 1993 5 40
    • (1993) Eur Respir J , vol.16 , pp. 5-40
    • Quanjer, P.H.1    Tammeling, G.J.2    Cotes, J.E.3    Pedersen, O.F.4    Peslin, R.5    Yernault, J.C.6
  • 25
    • 84962331075 scopus 로고    scopus 로고
    • Clement Clarke International Ltd Clement Clarke International Ltd Harlow, United Kingdom
    • Clement Clarke International Ltd Clement Clarke International Catalogue 2015 Clement Clarke International Ltd Harlow, United Kingdom
    • (2015) Clement Clarke International Catalogue
  • 26
    • 84962226992 scopus 로고    scopus 로고
    • Cayman Chemical Ann Arbor, MI
    • Cayman Chemical, Inc Cystenyl Leukotriene EIA Kit 2010 Cayman Chemical Ann Arbor, MI
    • (2010) Cystenyl Leukotriene EIA Kit
  • 27
    • 84962261557 scopus 로고    scopus 로고
    • Cayman Chemical Ann Arbor, MI
    • Cayman Chemical, Inc Tetranor-PGDM EIA Kit 2010 Cayman Chemical Ann Arbor, MI
    • (2010) Tetranor-PGDM EIA Kit
  • 28
    • 84962254256 scopus 로고    scopus 로고
    • Cayman Chemical Ann Arbor, MI
    • Cayman Chemical, Inc Prostaglandin E Metabolite EIA Kit 2010 Cayman Chemical Ann Arbor, MI
    • (2010) Prostaglandin e Metabolite EIA Kit
  • 29
    • 0037253429 scopus 로고    scopus 로고
    • Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease
    • M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 111 2003 180 186
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 180-186
    • Berges-Gimeno, M.P.1    Simon, R.A.2    Stevenson, D.D.3
  • 30
    • 80052438246 scopus 로고    scopus 로고
    • An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications
    • R.A. Dweik, P.B. Boggs, S.C. Erzurum, and et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications Am J Respir Crit Care Med 184 2011 602 615
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 602-615
    • Dweik, R.A.1    Boggs, P.B.2    Erzurum, S.C.3
  • 31
    • 84906944492 scopus 로고    scopus 로고
    • Exhaled nitric oxide: A biomarker integrating both lung function and airway inflammation changes
    • A. Haccuria, A. Michils, S. Michiels, and A. Van Muylem Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes J Allergy Clin Immunol 134 2014 554 559
    • (2014) J Allergy Clin Immunol , vol.134 , pp. 554-559
    • Haccuria, A.1    Michils, A.2    Michiels, S.3    Van Muylem, A.4
  • 32
    • 84896509428 scopus 로고    scopus 로고
    • Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS
    • A.B. Roos, M. Mori, R. Gronneberg, and et al. Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS PloS One 9 2014 e90018
    • (2014) PloS One , vol.9 , pp. e90018
    • Roos, A.B.1    Mori, M.2    Gronneberg, R.3
  • 33
    • 84902244482 scopus 로고    scopus 로고
    • Current evidence and future research needs for FeNO measurement in respiratory diseases
    • L. Bjermer, K. Alving, Z. Diamant, and et al. Current evidence and future research needs for FeNO measurement in respiratory diseases Respir Med 108 2014 830 841
    • (2014) Respir Med , vol.108 , pp. 830-841
    • Bjermer, L.1    Alving, K.2    Diamant, Z.3
  • 34
    • 0027752805 scopus 로고
    • The l-arginine-nitric oxide pathway
    • S. Moncada, and A. Higgs The l-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
    • (1993) N Engl J Med , vol.329 , pp. 2002-2012
    • Moncada, S.1    Higgs, A.2
  • 35
    • 84903273768 scopus 로고    scopus 로고
    • Relationship between methacholine challenge testing and exhaled nitric oxide in adult patients with suspected bronchial asthma
    • M. Giovannini, M. Valli, V. Ribuffo, and et al. Relationship between methacholine challenge testing and exhaled nitric oxide in adult patients with suspected bronchial asthma Eur Annals Allergy Clin Immunol 46 2014 109 113
    • (2014) Eur Annals Allergy Clin Immunol , vol.46 , pp. 109-113
    • Giovannini, M.1    Valli, M.2    Ribuffo, V.3
  • 36
    • 84918546420 scopus 로고    scopus 로고
    • Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury
    • F. Wu, W.S. Szczepaniak, S. Shiva, and et al. Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury Am J Physiol Lung Cell Mol Physiol 307 2014 L987 L997
    • (2014) Am J Physiol Lung Cell Mol Physiol , vol.307 , pp. L987-L997
    • Wu, F.1    Szczepaniak, W.S.2    Shiva, S.3
  • 37
    • 0031889921 scopus 로고    scopus 로고
    • Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury
    • E.A. Lianos, K. Guglielmi, and M. Sharma Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury Kidney Int 53 1998 645 653
    • (1998) Kidney Int , vol.53 , pp. 645-653
    • Lianos, E.A.1    Guglielmi, K.2    Sharma, M.3
  • 38
    • 1142285212 scopus 로고    scopus 로고
    • Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis
    • N. Higashi, M. Taniguchi, H. Mita, and et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis J Allergy Clin Immunol 113 2004 277 283
    • (2004) J Allergy Clin Immunol , vol.113 , pp. 277-283
    • Higashi, N.1    Taniguchi, M.2    Mita, H.3
  • 39
    • 0029664976 scopus 로고    scopus 로고
    • Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma
    • P. Sestini, L. Armetti, G. Gambaro, and et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma Am J Respir Crit Care Med 153 1996 572 575
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 572-575
    • Sestini, P.1    Armetti, L.2    Gambaro, G.3
  • 40
    • 84903596067 scopus 로고    scopus 로고
    • Aspirin activation of eosinophils and mast cells: Implications in the pathogenesis of aspirin-exacerbated respiratory disease
    • J.W. Steinke, J. Negri, L. Liu, S.C. Payne, and L. Borish Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease J Immunol 193 2014 41 47
    • (2014) J Immunol , vol.193 , pp. 41-47
    • Steinke, J.W.1    Negri, J.2    Liu, L.3    Payne, S.C.4    Borish, L.5
  • 41
    • 0034063822 scopus 로고    scopus 로고
    • Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients
    • M.L. Kowalski, R. Pawliczak, J. Wozniak, and et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients Am J Respir Crit Care Med 161 2000 391 398
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 391-398
    • Kowalski, M.L.1    Pawliczak, R.2    Wozniak, J.3
  • 42
    • 84901802659 scopus 로고    scopus 로고
    • 2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease
    • 2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease J Allergy Clin Immunol 133 2014 1692 1701.e1693
    • (2014) J Allergy Clin Immunol , vol.133 , pp. 1692-1701e1693
    • Laidlaw, T.M.1    Cutler, A.J.2    Kidder, M.S.3
  • 43
    • 84885693969 scopus 로고    scopus 로고
    • Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes
    • T. Liu, T.M. Laidlaw, H.R. Katz, and J.A. Boyce Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes Proc Natl Acad Sci U S A 110 2013 16987 16992
    • (2013) Proc Natl Acad Sci U S A , vol.110 , pp. 16987-16992
    • Liu, T.1    Laidlaw, T.M.2    Katz, H.R.3    Boyce, J.A.4
  • 44
    • 79959829982 scopus 로고    scopus 로고
    • Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma
    • J. Roca-Ferrer, F.J. Garcia-Garcia, J. Pereda, and et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma J Allergy Clin Immunol 128 2011 66 72.e61
    • (2011) J Allergy Clin Immunol , vol.128 , pp. 66-72e61
    • Roca-Ferrer, J.1    Garcia-Garcia, F.J.2    Pereda, J.3
  • 45
    • 59549107363 scopus 로고    scopus 로고
    • Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma
    • T. Yoshimura, M. Yoshikawa, N. Otori, S. Haruna, and H. Moriyama Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma Allergol Intl 57 2008 429 436
    • (2008) Allergol Intl , vol.57 , pp. 429-436
    • Yoshimura, T.1    Yoshikawa, M.2    Otori, N.3    Haruna, S.4    Moriyama, H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.